Hydroxy tetrahydro-naphthalenylurea derivatives
Details for Australian Patent Application No. 2003229734 (hide)
International Classifications
Event Publications
14 August 2003 Complete Application Filed
Priority application(s): 0227262.3 21.11.02 GB; 0210512.0 08.05.02 GB
15 January 2004 Application Open to Public Inspection
Published as AU-B-2003229734
19 February 2009 Assignment before Grant
Bayer Healthcare AG The application has been assigned to Xention Limited
19 February 2009 Application Accepted
Published as AU-B-2003229734
18 June 2009 Standard Patent Sealed
18 June 2009 Corrigenda
Applications OPI - Name Index Under the name Xention Limited, Inc., Application No. 2003229734, under INID (43) correct Publication Date to read 24 November 2003.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003229735-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH OXYTOCIN RECEPTOR (OXTR)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser